LUNG Q3 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$18M+30.9% YoY

Gross Profit

$13M73.7% margin

Operating Income

-$15M-85.9% margin

Net Income

-$15M-84.3% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+2.8%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$185M

Total Liabilities

$59M

Stockholders' Equity

$126M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$14M	+30.9%
Gross Profit	$13M	$10M	+28.3%
Operating Income	-$15M	-$14M	-8.9%
Net Income	-$15M	-$14M	-5.1%

Geographic Segments

UNITED STATES

$12M67%

EMEA

$5M27%

Asia Pacific

$814,0005%

Other International Geographical Areas

$164,0001%